Johnson & Johnson Shares Acquired by PFG Advisors

Institutional investor boosts stake in healthcare giant

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

PFG Advisors, an investment management firm, has increased its holdings in Johnson & Johnson (NYSE: JNJ) by 11.3% during the third quarter, according to a recent SEC filing. The fund now owns 43,778 shares of the company's stock, valued at $8,117,000 at the end of the quarter.

Why it matters

Johnson & Johnson is a major pharmaceutical and healthcare company, and changes in institutional ownership of its stock can signal broader market sentiment and investment trends in the sector. PFG Advisors' increased stake suggests confidence in J&J's long-term prospects.

The details

According to the SEC filing, PFG Advisors acquired an additional 4,427 shares of Johnson & Johnson during the third quarter, bringing its total holdings to 43,778 shares. The firm cited J&J's diversified product portfolio, strong brand recognition, and stable financial performance as reasons for the increased investment.

  • PFG Advisors acquired the additional shares during the third quarter of the year.

The players

PFG Advisors

An investment management firm that has increased its holdings in Johnson & Johnson.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets a broad range of pharmaceutical, medical device, and consumer health products.

Got photos? Submit your photos here. ›

The takeaway

The increased stake by PFG Advisors in Johnson & Johnson suggests that institutional investors remain confident in the healthcare giant's long-term growth prospects, despite any short-term market volatility.